Evergreening of Patents
Kashishipr
OCTOBER 20, 2021
After the changes of 2005, the Madras Patent Office , in 2006, rejected the application from Novartis for the drug Glivec stating that the said drug did not exhibit any major changes in therapeutic effectiveness over its pre-existing form, which was already patented outside India.
Let's personalize your content